LIN SUE-JEAN
SEC CIK 1867788 · EDGAR
BoughtSold
Most active insiders at ARQT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Watanabe Todd | See Remarks, Dir | — | $5.32M |
| 2 | Welgus Howard G. | Dir | — | $2.43M |
| 3 | Matsuda Masaru | See Remarks | — | $2.21M |
| 4 | Burnett Patrick | See Remarks | — | $2.02M |
| 5 | Leonard Keith R | Dir | — | $997.1K |
| 6 | Curran Terrie | Dir | — | $984.0K |
| 7 | Edwards Larry Todd | See Remarks | — | $968.4K |
| 8 | Krishnamohan Neha | Dir | — | $939.5K |
| 9 | LIN SUE-JEAN | Dir | — | $898.5K |
| 10 | Gilbert Halley E | Dir | — | $455.5K |
Transactions 9
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-26 06:14 | 2026-06-12 | STVN | Stevanato Group S.p.A. | LIN SUE-JEAN | Dir | A - Grant | $0.00 | +4,975 | 6,975 | +249% | $0 | |
| T | 2026-06-17 20:47 | 2026-06-15 | ARQT | Arcutis Biotherapeutics, Inc. | LIN SUE-JEAN | Dir | S - Sale | $24.38 | -4,946 | 27.6K | -15% | -$120.6K |
| D | 2026-06-09 21:21 | 2026-06-05 | ARQT | Arcutis Biotherapeutics, Inc. | LIN SUE-JEAN | Dir | A - Grant | $0.00 | +5,778 | 32.5K | +22% | $0 |
| DM | 2025-11-25 | 2025-11-24 | ARQT | Arcutis Biotherapeutics, Inc. | LIN SUE-JEAN | Dir | M - OptEx | $8.31 | +25.3K | 52.0K | +95% | +$210.0K |
| D | 2025-11-25 | 2025-11-24 | ARQT | Arcutis Biotherapeutics, Inc. | LIN SUE-JEAN | Dir | S - Sale+OE | $30.78 | -25.3K | 26.7K | -49% | -$777.9K |
| D | 2025-06-16 | 2025-06-12 | ARQT | Arcutis Biotherapeutics, Inc. | LIN SUE-JEAN | Dir | A - Grant | $0.00 | +7,609 | 26.7K | +40% | $0 |
| D | 2024-06-18 | 2024-06-14 | ARQT | Arcutis Biotherapeutics, Inc. | LIN SUE-JEAN | Dir | A - Grant | $0.00 | +10.1K | 19.1K | +113% | $0 |
| D | 2023-06-02 | 2023-05-31 | ARQT | Arcutis Biotherapeutics, Inc. | LIN SUE-JEAN | Dir | A - Grant | $0.00 | +4,375 | 8,987 | +95% | $0 |
| D | 2022-06-03 | 2022-06-01 | ARQT | Arcutis Biotherapeutics, Inc. | LIN SUE-JEAN | Dir | A - Grant | $0.00 | +4,312 | 4,612 | +1,437% | $0 |
Purchase Sale Sale after option exercise All abbreviations